Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **5-hydroxytryptamine receptor 7, isoform a (5-HT7A)** is a G protein-coupled receptor encoded by the HTR7 gene, with several splice variants including 7A. This receptor is widely distributed in the central nervous system and is implicated in the modulation of mood, cognition, circadian rhythm, and neurodevelopment. Antagonism of 5-HT7A, as exerted by vortioxetine and some other drugs, has been associated with antidepressant and pro-cognitive effects[1][3][4][5]. The 5-HT7A isoform specifically participates in cAMP-dependent intracellular signaling and regulates pathways such as PKA, EPAC, and mTOR, with downstream impact on synaptic plasticity and neuronal growth[4].
Antagonism of 5-HT7A inhibits cAMP production and downstream signaling, contributing to antidepressant, anxiolytic, and cognitive-enhancing effects
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-hydroxytryptamine receptor 7, isoform a (5-HT7A).